Morgan Stanley Painreform Ltd. Transaction History

Morgan Stanley

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 13, 2022	SELL	$0.88 - $1.56 $24,295 - $43,068	-27,608 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.26 - $2.83 $34,786 - $78,130	27,608 New	27,608 $37,000

Ticker PRFX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 10,634,200
Market Cap $5.64M
Description
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-oper...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.